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Abstract Intestinal neuronal dysplasia is a controversial
form of dysganglionosis that has been described both as
an isolated disorder and in association with Hirsch-
sprungs disease. It has been blamed for the bad outcome
of bowel function in patients operated on for Hirsch-
sprungs disease. According to various authors, intesti-
nal neuronal dysplasia could be a primary disorder or
secondary to other diseases of the bowel. The aim of this
study was to assess the plasticity of the enteric nervous
system in patients with Hirschsprungs disease-associ-
ated intestinal neuronal dysplasia and its ability to
evolve spontaneously to normal innervation patterns.
Since we prospectively introduced the assessment of the
enteric nervous system of the ganglionated bowel in
patients operated on for Hirschsprungs disease, 31 pa-
tients have been operated on for Hirschsprungs disease
in our institution between 1995 and 2002. Among these
patients, nine suﬀered postoperatively from severe con-
stipation and ﬁve from bouts of entocolitis. IND was
found in eight of them. We studied the evolution of the
innervation in three of these patients by repeated serial
full-thickness biopsies of the colon. All three patients
underwent a colostomy before or after the pull-through
procedure. Histopathological assessment of the enteric
nervous system was made with conventional acetylcho-
linesterase histochemistry, rapid acetylcholinesterase
histochemistry and immunohistochemistry for the Pro-
tein Gene Product 9.5 and the antigen CD56. This
evolution was compared with the clinical outcome of
bowel function. In our three patients with Hirsch-
sprungs disease-associated intestinal neuronal dysplasia,
this form of dysganglionosis evolved to normal inner-
vation patterns within a period ranging from 9 to
18 months. This evolution was accompanied by an
improvement of bowel function in all. We conclude that
Hirschsprungs disease-associated intestinal neuronal
dysplasia can evolve to a normal innervation, at least
under certain circumstances such as a colostomy. Spe-
ciﬁc histopathological techniques are required to assess
accurately the enteric nervous system.
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Introduction
Several forms of histopathological abnormalities of the
enteric nervous system (ENS) and particularly of para-
sympathic innervation have been described. Among
them, intestinal neuronal dysplasia type B (IND) and
other forms of dysganglionosis such as hypoganglionosis
and non-classiﬁable dysganglionosis (NCD) are still
debated entities [1, 4, 9, 14, 20].
Some authors consider IND to be a primary disease
[3, 10, 21], but it might likewise be secondary to
obstruction, inﬂammation or other pathological condi-
tions of the bowel [18, 19, 25]. It also has ill-deﬁned
clinical consequences. IND has been reported as an
isolated lesion (i.e., not associated with other innerva-
tion disorders) [21, 26, 27] and has been found in pa-
tients with Hirschsprungs disease (HD), proximal to the
aganglionosis. It also has been blamed for the bad out-
come of bowel function (BF) after the pull-through
procedure (PT) [6, 22]. In addition, hypoganglionosis
has been found to be an isolated innervation disorder
and to occur in association with aganglionosis in the
transition zone [7, 14, 20]. It also has been mentioned as
a cause of postoperative complications after surgery for
HD. Milder forms of innervation changes of the ENS
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such as an increased number of ganglia and hypertro-
phied nerves in the submucosa (SM) have been found.
The clinical signiﬁcance of these forms of NCD is still
puzzling as well [4].
Reports have described spontaneous favourable
evolution of isolated IND [18, 26], conﬁrmed by histo-
pathological studies. These observations could explain
reports of long-term improvement of BF in patients with
a bad short-term outcome after surgery for HD [17, 24].
This clinical evolution has already been described in
other reports [2, 13].
Our hypothesis was that HD-associated IND could
evolve to normal innervation patterns. To our knowl-
edge, this form of plasticity has not yet been conﬁrmed
by histopathological studies. We thus decided to com-
pare the clinical follow-up of BF with the evolution of
the histological patterns of the ENS in three patients
who underwent surgery for HD. In order to avoid
confusion and debate about IND [1], we believe that
only clear criteria should be used for its diagnosis. Al-
though other features have been described in association
with IND (e.g., ectopic ganglion cells and marked ace-
tylcholinesterase activity in the mucosa in the muscularis
mucosae and around vessels [6]), our diagnosis was
based on the presence of submucosal giant ganglia
containing more than seven mature cells [15]. Criteria
proposed by Meier-Ruge were used for the diagnosis of
other types of dysganglionosis [8, 13].
Materials and methods
Patients
Since 1995, we have prospectively introduced a systematic assess-
ment of the ENS of the ganglionated bowel [16] in patients oper-
ated on for HD. Between 1995 and 2002, 31 patients were operated
on for HD at our institution. In eight patients, IND was found in
association with HD. Three of these patients were included in this
study because of the severity of the outcome of their BF. In two of
them (cases 1 and 2) a colostomy had to be performed after the PT
because of a bad outcome of the BF, and the ﬁrst diagnosis of IND
was made at that time. Of note, colostomies had to be performed in
these patients because a cautious follow-up could not be ensured in
their native country. Therefore, creating a colostomy seemed to be
the only safe method to avoid enterocolitis, which could have been
potentially fatal. Biopsies were performed prior to PT in the last
patient (case 3), who was included in a prospective study that
comprised the assessment of innervation above the aganglionic
zone (AZ) with serial full-thickness biopsies before proceeding to
PT [16].
Histopathological evaluation
Intraoperative evaluation of the innervation was carried out either
with conventional hematoxylin and eosin (HE) staining or with the
rapid acetyl-cholinesterase (AChE) reaction [7]. All samples were
thereafter assessed with conventional AChE histochemistry
according to Karnovsky and Roots [5] and immunohistochemistry
for protein gene product 9.5 (PGP 9.5), a cytoplasmic marker
speciﬁc for the neural system [8] and for the antigen CD56 (CD56),
a killer-cell associated antigen whose expression is comparable to
that of NCAM [12].
Rapid AChE staining
Each specimen was snap-frozen in Tissue-Tek OCT compound
(Sakura Finetek, Torrance, USA). Frozen sections (6 lm thick)
were cut serially.
The incubation medium was 40 mg of acetylthiocholine iodide,
52 ml of 0.1 mM natrium acetate buﬀer (pH 6.0, adjusted with
0.1 M acetic acid), 3.8 ml of 0.1 M tri-natrium citrate, 4 ml of
30 mM copper sulfate, 1.6 ml of 4 mM tetraisopropyl pyrophos-
phoramide (iso-OMPA), 8 ml of distilled water and 8 ml of 5 mM
potassium hexacyanoferrate III. The sections were incubated at
37C for 10 min in this medium and washed in distilled water. They
were then treated by freshly prepared 3,3-Diaminobenzidine-tetr-
ahydrochloride dihydrate (DAB, Fluka Chemie, Buchs, Switzer-
land), 25 mg in 100 ml Tris buﬀered saline (TBS: 0.05 M Tris,
0.9% sodium chloride, pH 7.6) containing 0.015% hydrogen per-
oxide for 5 min, rinsed in tap water and counterstained in Mayers
acid-free hematoxylin, dehydrated and mounted in Eukitt.
Tissue preparation for immunohistochemistry
The tissue was ﬁxed in buﬀered formalin (4% paraformaldehyde
solution in phosphate buﬀered saline), dehydrated and embedded in
paraﬃn wax. Paraﬃn sections (6 lm thick) were cut and mounted
on 3-aminopropyl-triethoxysilane-coated glass slides, deparaﬃ-
nized in xylol, immersed for 45 min in methanol with 0.3%
hydrogen peroxide to block endogenous peroxidase activity and
rehydrated through graded alcohols. Sections were then subjected
to microwave pre-treatment in 10 mM citrate buﬀer (pH 6) for
20 min, according to the method of Shi et al. [23] and rinsed in TBS.
Immunohistochemistry antibodies
For the CD56 immunodetection, the ﬁrst antibody was a mouse
anti-CD56 monoclonal antibody (1:50, CD56, clone 1B6; Novo-
castra, Newcastle upon Tyne, UK), and the second antibody was a
biotinylated horse antimouse IgG (1:200, Vector Laboratories,
Burlingame, USA).
For the PGP9.5 immunodetection the ﬁrst antibody was a
rabbit anti-PGP 9.5 polyclonal antibody (1:800, PGP 9.5, Anawa,
Wangen, Switzerland), and the second antibody was a biotinylated
goat antirabbit IgG (1:400, Vector Laboratories).
Immunohistochemical procedures
To reduce non-speciﬁc antibody binding, the sections were incu-
bated in normal horse serum for CD56 and normal goat serum for
PGP 9.5 (1:30 in TBS) for 10 min, then with the ﬁrst antibody
mixed in TBS containing 5% non-fat dried milk for 30 min at room
temperature. They were then washed in TBS and incubated with
the second antibody for 30min at room temperature. After washing
in TBS, sections were incubated in avidin-biotin-horseradish per-
oxidase complex according to the manufacturers indications
(Vectastain ABC kit, Vector Laboratories). Peroxidase was visu-
alised by freshly prepared DAB, 50 mg in 100 ml TBS containing
0.01% hydrogen peroxide and counterstained in Mayers acid-free
hematoxylin, dehydrated and mounted in Eukitt. Negative controls
were performed using the procedure described above omitting the
ﬁrst antibody.
Results
All three patients had a neo-natal onset of symptoms.
IND was found in serial biopsies harvested above the
AZ. In all sections, diagnosis of IND was made on the
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basis of the presence of submucosal giant ganglia con-
taining more than seven mature cells. Accompanying
submucosal marked nerve hypertrophy was seen in all
instances.
Case 1
The patient was referred to our institution with a
colostomy that had been created on the descending co-
lon by 2 months of age. He underwent PT 6 months
later. Aganglionosis was 11 cm long, and intraoperative
HE staining showed a normal innervation above the AZ,
but postoperative AChE and immunohistochemistry
made on the resected colon displayed IND up to 10 cm
above the AZ (Figs. 1, 2A). Postoperatively, the patient
had severe constipation and multiple episodes of
enterocolitis that mandated a colostomy 1 month later.
During this procedure, ﬁve full-thickness colon biopsies
5·10 mm each were harvested up to the caecum. They
displayed mosaic-like innervation changes with IND in
two biopsies (Fig. 2B) and marked nerve hypertrophy in
the SM in three. Six months later, biopsies were repeated
at the same levels as before. At that time, a marked
nerve hypertrophy was seen in the SM without criteria
for IND (Figs. 2C, 3). The colostomy was then closed,
but once again the patient had severe constipation and
multiple bouts of enterocolitis. It was decided to place a
new colostomy and to keep it for a longer period of time.
Biopsies were repeated after 18 months. At that time,
only a moderate nerve hypertrophy was seen and the
colostomy was closed (Figs. 2D, 4). The patient had
normal bowel movements and good continence with
follow-up of 4 years.
Case 2
The patient was referred to our institution with a
colostomy that had been created by 10 months of age on
the mid-descending colon. PT was performed 4 months
later. The colon was massively dilated above the colos-
tomy. The AZ was 35 cm long, and intraoperative
biopsies assessed with rapid AChE staining showed that
colostomy had been made in the AZ. Serial full-thick-
ness biopsies also displayed IND 10 and 24 cm above
Fig. 2 Case 1. Histopathology of biopsies: (A) at time of pull-
though (PT), (B) 1 month after PT, (C) 7 months after PT and (D)
18 months after PT. Measurements taken above the excavatio
rectovesicalis. ER Excavatio rectovesicalis, AZ aganglionic zone,
IND intestinal neuronal dysplasia, MNH marked nerve hypertro-
phy, NH moderate nerve hypertrophy. Arrow indicates level of
resection, oval represents colostomy
Fig. 1 Case 1. Transverse colon. Submucosal giant ganglion (G)
(CD 56·200)
Fig. 3 Case 1. Transverse colon. Submucosal ganglion (G) and
markedly hypertrophied nerve ﬁber (HF) (PGP 9.5·100)
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the AZ (Fig. 5A). Because of multiple episodes of
enterocolitis and severe constipation in spite of conser-
vative treatment for 1 month, we decided in favour of a
colostomy. During this procedure, three biopsies were
harvested along the colon. They all conﬁrmed the pres-
ence of IND (Fig. 5B). The patient kept the colostomy
for 1 year. At this time, renewed biopsies were made at
the same levels as before. They all showed a normal
innervation (Fig. 5C). The colostomy was consequently
closed. With a follow-up of 4 years, the patient had
good continence and daily bowel movements.
Case 3
This patient was referred to our institution as a neonate.
After conﬁrmation of HD with rectal suction biopsies,
she was ﬁrst managed with rectal washouts. By 2.5
months of age, we ﬁrst assessed the colon innervation
with ﬁve full-thickness colon biopsies that showed a 15-
cm-long aganglionosis and IND 10 and 15 cm above the
AZ (Fig. 6A). A colostomy was then created. After
9 months, serial biopsies were repeated at the same
levels as before. They all showed a normal innervation
with only moderate nerve hypertrophy in two. PT was
thus undertaken. Immunohistopathological examination
of the resected colon displayed the presence of IND
limited to 3 cm above the AZ and to the proximal stoma
of the colostomy (Fig. 6B). The patient has normal BF
with 6 years of follow-up.
Discussion
Dysganglionosis consists of a broad spectrum of inner-
vation disorders that may be associated in the same
patient. On one side of the spectrum, hypoganglionosis
might represent the transition between normal innerva-
tion and aganglionosis. When ignored, it can be the
cause of complications after surgery for HD [7, 14, 20].
On the other side of the spectrum, IND type B is
characterised by a hyperganglionosis and hypertrophied
nerves in the SM, as well as ectopic nerve cells in the LP
[8, 13, 15]. It has been described as an isolated disorder
[10, 21, 26, 27] and reported in association with other
pathological conditions of the bowel like necrotising
enterocolitis, mucoviscidosis, bowel obstruction in neo-
nates and anorectal malformations with secondary
megacolon or constipation [18, 19, 25]. IND could
therefore be considered either as a cause or a conse-
Fig. 5 Case 2. Histopathology of biopsies: (A) at time of pull-
through (PT), (B) 1 month after PT and (C) 1 year after PT.
Measurements taken above the excavatio rectovesicalis. ER
Excavatio rectovesicalis, AZ aganglionic zone, IND intestinal
neuronal dysplasia. Arrow indicates level of resection, oval
represents colostomy
Fig. 6 Case 3. Histopathology of biopsies: (A) at time of biopsies
and colostomy and (B) after 9 months at the time of pull-through.
Measurements taken above the excavatio rectovaginalis. ER
Excavatio rectovaginalis, AZ aganglionic zone, IND intestinal
neuronal dysplasia, NH moderate nerve hypertrophy. Oval
represents colostomy, arrow indicates level of resection
Fig. 4 Case 1. Transverse colon. Normal submucosal ganglions (G)
and moderately hypertrophied nerve ﬁber (N) (PGP 9.5·100)
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quence of these diseases. Also, it has been encountered
in as many as 40% of patients with HD, proximal to the
AZ and blamed for the bad postoperative outcome of
BF in these patients [6, 22].
These innervation changes remain controversial [1, 9].
This in part could be due to the sophisticated methods
required to assess them, such as the acetyl-cholinesterase
histochemistry and immunohistochemistry techniques,
but also to the lack of agreement in the criteria used to
classify these changes. Of note, our experience corrob-
orates the reports of overlooked dysganglionosis when
no more than ‘‘conventional’’ staining techniques
like HE were used [6, 7]. Rapid AChE permits an
intraoperative exploration of the innervation, but the
ﬁnal diagnosis should be conﬁrmed with speciﬁc
histopathological techniques like conventional
AChE after Karnovsky and Roots and immunohisto-
chemistry for PGP 9.5 and CD56. We would therefore
suggest applying these diagnostic methods on full-
thickness biopsies as soon as innervation disorders are
suspected.
Simpser et al. [26] have reported the spontaneous
regression of isolated IND in one patient. Same reports
were made by Rintala and al. in infants with bowel
obstruction [18]. Since 1995, we prospectively assessed
the ENS of the ganglionated bowel above the AZ at
the time of PT. From 1995 to 2002, 31 patients were
operated on for HD in our institution. Nine had severe
constipation after PT, and IND was found in eight of
them. In all of these patients, BF improved in a period
of time ranging from 1 to 5 years. In three patients
who were repeatedly histologically reassessed because
of the severity of their complications, this particular
dysganglionosis evolved to normal innervation within a
period ranging from 9 to 18 months. In one patient
(case 1), this evolution occurred stepwise. In the biop-
sies repeated after 6 months, criteria for IND were not
met, but changes of the innervation such as a marked
nerve hypertrophy in the SM were still present. Con-
sidering that they were not found in the biopsies re-
peated after 18 months, these changes may represent a
milder form of hyperplasia of the parasympathic ner-
vous system and be intermediate innervation patterns
between IND and normal innervation. The moderate
nerve hypertrophy that was encountered in two pa-
tients did not have any clinical implication when seen
as an isolated ﬁnding. Nevertheless, when found in a
patient with disorders of the BF, it should raise the
suspicion of the presence of more severe types of
dysganglionosis coexisting in the same region of the
bowel, and this should be searched for.
These observations have led us to the hypothesis
that IND could be responsible for the bad postoper-
ative short-term outcome of BF in some patients with
HD and that the long-term improvement of BF re-
ported by some authors [17, 24] might be explained by
the normalisation of innervation patterns of the colon
proximal to the aganglionosis, at least in some of
these patients.
Distension or inﬂammation of the bowel wall, as well
as stool retention, can explain the development or the
persistence of IND. Colostomies that had been placed to
avoid stool retention and consequent dilatation of the
bowel may therefore have contributed to the plasticity
encountered in our patients. Marty et al. [11] have suc-
cessfully proposed postoperative repeated irrigations in
all patients operated on for HD in order to reduce
postoperative complications. This method may have had
the same result as a colostomy on the bowel wall and
thus on ENS.
Although some authors have considered IND as a
primary disease and proposed resection of the in-
volved bowel segments [2, 27], others have suggested
conservative treatment with saline washouts [21, 26].
Our study shows that IND might evolve to normal
innervation. Also, postnatal changes in the neuronal
density of the myenteric plexus have been described
[28], and IND changes might be part of this overall
evolution. Dealing with this innervation disorder
therefore requires being aware of its ability to have a
certain degree of plasticity in order to avoid prevent-
able major surgical procedures. The ﬁnding of IND is
an indication for daily bowel washouts, or for a
colostomy in selected cases. According to the outcome
of BF, biopsies should thereafter be repeated after a
delay of about 12 months in order to assess the
evolution of innervation patterns.
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